Equity Research, Broker Reports, and media content on GALAPAGOS NV

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about GALAPAGOS NV
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on GALAPAGOS NV. We currently have 0 research reports from 0 professional analysts.

Open
79.0
Volume
0.6m
Range
78.7/80.9
Market Cap
3,918,166,984m
52 Week
39.5/89.8
Date Source Announcement
17May17 21:00 GNW Galapagos creates new warrant plan
17May17 06:30 GNW Galapagos to hold Annual R&D Update 2017 on 20 June
15May17 21:00 GNW Seven abstracts on filgotinib accepted by EULAR 2017
07May17 15:35 GNW Galapagos presents three posters on filgotinib in Crohn's disease at DDW® 2017
29Apr17 06:30 GNW Galapagos presents pre-clinical data with selective ADAMTS-5 inhibitor GLPG1972 for osteoarthritis at OARSI
27Apr17 21:00 GNW Galapagos reports first quarter 2017 results
25Apr17 21:00 GNW Galapagos announces new Phase 2 Proof-of-Concept study with filgotinib in cutaneous lupus erythematosus
  • Frequency of research reports

     

  • Research reports on

    GALAPAGOS NV

  • Providers covering

    GALAPAGOS NV